Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade

EMBO Journal

Volumn 17, Issue 22, 1998, Pages 6633-6648

  Galbiati, Ferruccio ^a   Volonté, Daniela ^a   Engelman, Jeffrey A ^a   Watanabe, Genichi ^a   Burk, Robert ^a   Pestell, Richard G ^a   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Caveolae; Caveolin 1; Contact inhibition; Ras p42 44 MAP kinase cascade; Tumor suppressor activity

Indexed keywords

CAVEOLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME 7Q; CONTROLLED STUDY; DOWN REGULATION; HYPERACTIVITY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0032538790     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.22.6633     Document Type: Article

References (65)

1. Bretscher, M. and Whytock, S. (1977) Membrane-associated vesicles in fibroblasts. J. Ultrastruc. Res., 61, 215-217.
2. Couet, J., Li, S., Okamoto, T., Scherer, P.S. and Lisanti, M.P. (1997a) Molecular and cellular biology of caveolae: paradoxes and plasticities. Trends Cardiovasc. Med., 7, 103-110.
3. Couet, J., Li, S., Okamoto, T., Ikezu, T. and Lisanti, M.P. (1997b) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem., 272, 6525-6533.
4. Couet, J., Sargiacomo, M. and Lisanti, M.P. (1997c) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem., 272, 30429-30438.
5. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
6. Engelman, J.A., Wycoff, C.C., Yasuhara, S., Song, K.S., Okamoto, T. and Lisanti, M.P. (1997) Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem., 272, 16374-16381.
7. Engelman, J.A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D.S. and Lisanti, M.P. (1998a) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett., 428, 205-211.
8. Engelman, J.A. et al. (1998b) Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J. Biol. Chem., 273, 20448-20455.
9. Engelman, J.A., Zhang, X.L., Galbiati, F. and Lisanti, M.P. (1998c) Chromosomal localization, genomic organization and developmental expression of the murine caveolin gene family (Cav-1, -2 and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett., 429, 330-336.
10. Engelman, J.A., Zhang, X.L. and Lisanti, M.P. (1998d) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett., 436, 403-410.
11. Fan, J.Y., Carpentier, J.-L., van Obberghen, E., Grunfeld, C., Gorden, P. and Orci, L. (1983) Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J. Cell Sci., 61, 219-230.
12. Forbes, M.S., Rennels, M. and Nelson, E. (1979) Caveolar systems and sarcoplasmic reticulum in coronary smooth muscle cells. J. Ultrastruc. Res., 67, 325-339.
13. Fra, A.M., Masserini, M., Palestini, P., Sonnino, S. and Simons, K. (1995a) A photo-reactive derivative of ganglioside GM1 specifically crosslinks VIP21-caveolin on the cell surface. FEBS Lett., 375, 11-14.
14. Fra, A.M., Williamson, E., Simons, K. and Parton, R.G. (1995b) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. USA, 92, 8655-8659.
15. Furuchi, T. and Anderson, R.G.W. (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem., 273, 21099-21104.
16. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J.E. and Sessa, W.C. (1996) Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for caveolae localization. Proc. Natl Acad. Sci. USA, 93, 6448-6453.
17. Garcia-Cardena, G., Martasek, P., Siler-Masters, B.S., Skidd, P.M., Couet, J.C., Li, S., Lisanti, M.P. and Sessa, W.C. (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem., 272, 25437-25440.
18. Glenney, J.R. (1989) Tyrosine phosphorylation of a 22 kDa protein is correlated with transformation with Rous sarcoma virus. J. Biol. Chem., 264, 20163-20166.
19. Glenney, J.R. (1992) The sequence of human caveolin reveals identity with VIP 21, a component of transport vesicles. FEBS Lett., 314, 45-48.
20. Glenney, J.R. and Soppet, D. (1992) Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in RSV-transformed fibroblasts. Proc. Natl Acad. Sci. USA, 89, 10517-10521.
21. Huang, H., Qian, C., Jenkins, R.B. and Smith, D.I. (1998) FISH mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosom. Cancer, 21, 152-159.
22. Ishwad, C.S., Ferrell, R.E., Hanley, K., Davare, J., Meloni, A.M., Sandberg, A.A. and Surti, U. (1997) Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosom. Cancer, 19, 156-160.
23. Jenkins, R., Takahashi, S., DeLacey, K., Bergstralh, E. and Lieber, M. (1998) Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q and 18q in stage T3N0M0 prostate cancer. Genes Chromosom. Cancer, 21, 131-143.
24. Ju, H., Zou, R., Venema, V.J. and Venema, R.C. (1997) Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem., 272, 18522-18525.
25. Kerr, J. et al. (1996) Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene, 13, 1815-1818.
26. Koike, M., Takeuchi, S., Yokota, J., Park, S., Hatta, Y., Miller, C.W., Tsuruoka, N. and Koeffler, H.P. (1997) Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosom. Cancer, 19, 1-5.
27. Koleske, A.J., Baltimore, D. and Lisanti, M.P. (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl Acad. Sci. USA, 92, 1381-1385.
28. Kurzchalia, T., Dupree, P., Parton, R.G., Kellner, R., Virta, H., Lehnert, M. and Simons, K. (1992) VIP 21, A 21-kDa membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol., 118, 1003-1014.
29. Lee, S.W., Reimer, C.L., Oh, P., Campbell, D.B. and Schnitzer, J.E. (1998) Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 16, 1391-1397.
30. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., Nishimoto, I. and Lisanti, M.P. (1995) Evidence for a regulated interaction between hetero-trimeric G proteins and caveolin. J. Biol. Chem., 270, 15693-15701.
31. Li, S., Couet, J. and Lisanti, M.P. (1996a) Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, Caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem., 271, 29182-29190.
32. Li, S., Song, K.S. and Lisanti, M.P. (1996b) Expression and characterization of recombinant caveolin: Purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem., 271, 568-573.
33. Li, S., Galbiati, F., Volonte, D., Sargiacomo, M., Engelman, J.A., Das, K., Scherer, P.E. and Lisanti, M.P. (1998) Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett., 434, 127-134.
34. Liang, H., Fairman, J., Claxton, D.F., Nowell, P.C., Green, E.D. and Nagarajan, L. (1998) Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc. Natl Acad. Sci. USA, 95, 3781-3785.
35. Lisanti, M.P., Scherer, P., Tang, Z.-L. and Sargiacomo, M. (1994a) Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol., 4, 231-235.
36. Lisanti, M.P., Scherer, P.E., Vidugiriene, J., Tang, Z.-L., Hermanoski-Vosatka, A., Tu, Y.-H., Cook, R.F. and Sargiacomo, M. (1994b) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol., 126, 111-126.
37. Liu, P., Ying, Y., Ko, Y.-G. and Anderson, R.G.W. (1996) Localization of the PDGF-stimulated phosphorylation cascade to caveolae. J. Biol. Chem., 271, 10299-10303.
38. Liu, J., Oh, P., Horner, T., Rogers, R.A. and Schnitzer, J.E. (1997a) Organized endothelial cell signal transduction in caveolae. J. Biol. Chem., 272, 7211-7222.
39. Liu, P., Ying, Y.S. and Anderson, R.G.W. (1997b) PDGF activates MAP kinase in isolated caveolae. Proc. Natl Acad. Sci. USA, 94, 13666-13670.
40. Michel, J.B., Feron, O., Sase, K., Prabhakar, P. and Michel, T. (1997) Caveolin versus Calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem., 272, 25907-25912.
41. Mineo, C., James, G.L., Smart, E.J. and Anderson, R.G.W. (1996) Localization of EGF-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem., 271, 11930-11935.
42. Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T. and Simons, K. (1995) VIP21/caveolin is a cholesterol-binding protein. Proc. Natl Acad. Sci. USA, 92, 10339-10343.
43. Nishizuka, S., Tamura, G., Terashima, M. and Satodate, R. (1997) Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. Br. J. Cancer, 76, 1567-1571.
44. Oka, N., Yamamoto, M., Schwencke, C., Kawabe, J., Ebina, T., Couet, J., Lisanti, M.P. and Ishikawa, Y. (1997) Caveolin interaction with protein kinase C: isoenzyme-dependent regulation of kinase activity by the caveolin-scaffolding domain peptide. J. Biol. Chem., 272, 33416-33421.
45. Okamoto, T., Schlegel, A., Scherer, P.E. and Lisanti, M.P. (1998) Caveolins, a family of scaffolding proteins for organizing 'pre-assembled signaling complexes' at the plasma membrane. J. Biol. Chem., 273, 5419-5422.
46. Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y., Glenney, J.R. and Anderson, R.G.W. (1992) Caveolin, a protein component of caveolae membrane coats. Cell, 68, 673-682.
47. Sager, R. et al. (1994) RNA genetics of breast cancer: maspin as a paradigm. Cold Spring Harbor Symp. Quant. Biol., LIX, 537-546.
48. Sargiacomo, M., Scherer, P.E., Tang, Z.-L., Kubler, E., Song, K.S., Sanders, M.C. and Lisanti, M.P. (1995) Oligomeric structure of caveolin: Implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA, 92, 9407-9411.
49. Scherer, P.E., Lisanti, M.P., Baldini, G., Sargiacomo, M., Corley-Mastick, C. and Lodish, H.F. (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol., 127, 1233-1243.
50. Scherer, P.E., Tang, Z.-L., Chun, M.C., Sargiacomo, M., Lodish, H.F. and Lisanti, M.P. (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem., 270, 16395-16401.
51. Scherer, P.E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H.F. and Lisanti, M.P. (1996) Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Natl Acad. Sci. USA, 93, 131-135.
52. Scherer, P.E. et al. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem., 272, 29337-29346.
53. Severs, N.J. (1988) Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artefact. J. Cell Sci., 90, 341-348.
54. Shaul, P.W., Smart, E.J., Robinson, L.J., German, Z., Yuhanna, I.S., Ying, Y., Anderson, R.G.W. and Michel, T. (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem., 271, 6518-6522.
55. Shridhar, V., Sun, Q.C., Miller, O.J., Kalemkerian, G.P., Petros, J. and Smith, D.I. (1997) Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene, 15, 2727-2733.
56. Simionescu, N. and Simionsecu, M. (1983) The cardiovascular system. In Weiss, L. (ed.), Histology: Cell and Tissue Biology. Elsevier Biomedical. New York, NY, pp. 371-433.
57. Smart, E.J., Ying, Y., Mineo, C. and Anderson, R.G.W. (1995) A detergent free method for purifying caveolae membrane from tissue cultured cells. Proc. Natl Acad. Sci. USA, 92, 10104-10108.
58. Song, K.S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M. and Lisanti, M.P. (1996a) Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J. Biol. Chem., 271, 9690-9697.
59. Song, K.S., Scherer, P.E., Tang, Z.-L., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D.S. and Lisanti, M.P. (1996b) Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem., 271, 15160-15165.
60. Tang, Z.-L., Scherer, P.E. and Lisanti, M.P. (1994) The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C. Gene, 147, 299-300.
61. Tang, Z.-L., Scherer, P.E., Okamoto, T., Song, K., Chu, C., Kohtz, D.S., Nishimoto, I., Lodish, H.F. and Lisanti, M.P. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem., 271, 2255-2261.
62. Wang, X.L., Uzawa, K., Miyakawa, A., Shiiba, M., Watanabe, T., Sato, T., Miya, T., Yokoe, H. and Tanzawa, H. (1998) Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1. Int. J. Cancer, 75, 671-674.
63. Way, M. and Parton, R. (1995) M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett., 376, 108-112.
64. Zenklusen, J.C., Rodriguez, L.V., LaCava, M., Wang, Z., Goldstein, L.S. and Conti, C.J. (1996).Novel susceptibility locus for mouse hepatomas: evidence for a conserved tumor suppressor gene. Genome Res., 6, 1070-1076.
65. Zenklusen, J.C., Hodges, L.C. and Conti, C.J. (1997) Loss of heterozygosity on murine chromosome 6 in two-stage carcinogenesis: evidence for a conserved tumor suppressor gene. Oncogene, 14, 109-114.